Oxygen free radicals and platelet activation

Free Radical Biology and Medicine

Volumn 22, Issue 6, 1997, Pages 999-1006

  Iuliano, Luigi ^a   Colavita, Angela Rita ^a   Leo, Roberto ^a   Praticò, Domenico ^b   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antioxidants; Atherosclerosis; Free Radicals; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; DIPYRIDAMOLE; HEMOGLOBIN; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN RADICAL;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANTIOXIDANTS; BLOOD PLATELETS; FREE RADICALS; HUMANS; OXYGEN; PLATELET ACTIVATION;

ANIMALIA; THROMBUS;

EID: 0031050511     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00488-1     Document Type: Article

References (76)

1. Marcus A. J., Silk S. T., Safier L. B., Ullmann H. L. Superoxide production and reducing activity in human platelets. J. Clin. Invest. 59:1977;149-158.
2. Cesbron J. Y., Capron A., Vargaftig B. B., Lagarde M., Pincemail J., Braquet P., Toelman H., Joseph M. Platelets mediate the action of diethylcarbamazine on microfilariae. Nature. 325:1987;533-536.
3. Iuliano L., Praticò D., Ghiselli A., Bonavita M. S., Violi F. Superoxide dismutase triggers activation of "primed" platelets. Arch. Biochem. Biophys. 289:1991;180-183.
4. Leoncini G., Maresca M., Colao C. Oxidative metabolism of human platelets. Biochem. Int. 25:1991;647-655.
5. Finazzi-Agrò A., Menichelli A., Persiani M., Biancini G., Del Principe D. Hydrogen peroxide release from human blood platelets. Biochim. Biophys. Acta. 718:1982;21-25.
6. Salvemini D., De Nucci G., Sneddon J. M., Vane J. R. Superoxide anions enhance platelet adhesion and aggregation. Br. J. Pharmacol. 97:1989;1145-1150.
7. Del Principe D., Menichelli A., De Matteis W., Di Corpo M. L., Di Giulio S., Finazzi-Agrò A. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett. 185:1985;142-146.
8. Violi F., Ghiselli A., Iuliano L., Alessandri C., Cordova C., Balsano F. Influence of hydroxyl radical scavengers on platelet function. Haemostasis. 18:1988;91-98.
9. Iuliano L., Pedersen J. Z., Praticò D., Rotilio G., Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur. J. Biochem. 221:1994;695-704.
10. Leo R., Ghiselli A., Iuliano L., Violi F. Detection of hydroxyl radicals by the salicylate bis-hydroxylation during arachidonic acid-dependent platelet activation. Thromb. Haemostas. 73:1995;A347.
11. Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox-active forms. Science. 258:1992;1898-1902.
12. Muruganandam A., Mutus B. Isolation of nitric oxide synthase from human platelets. Biochim. Biophys. Acta. 1200:1994;1-6.
13. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
14. Ribeiro J. M. C., Hazzard J. M. H., Nussenzveig R. H., Champagne D. E., Walker F. A. Reversible binding of nitric oxide by a salivary heme protein from a blood sucking insect. Science. 260:1993;539-541.
15. Cross A. R., Jones O. T. G. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Biochem. J. 237:1986;111-116.
16. Salvemini D., Radziszewski W., Mollace V., Moore A., Willoughby D., Vane J. Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation. Eur. J. Pharmacol. 199:1991;15-18.
17. Pou S., Pou W. S., Bredt D. S., Snyder S. H., Rosen G. M. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267:1992;24173-24176.
18. Marnett L. J., Bienkowski M. J., Pagels W. R. Oxygen 18 investigation of the prostaglandin synthetase-dependent co-oxidation of diphenylisobenzofuran. J. Biol. Chem. 254:1979;5077-5082.
19. Egan, R. W.; Gale, P. H.; Baptista, E. M.; Kennicott, K. L.; Vanden Henvel, W. S.; Waletr, R. W.; Fagerness, P. E.; Kuebl, F. A., Jr. Oxidation reactions by prostaglandin cyclooxygenase hydroperoxidase. J. Biol. Chem. 256:72-61; 1981.
20. Kontos H. A., Wei E. P., Ellis E. F., Jenkins L. W., Rowe G. T., Hess M. L. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ. Res. 57:1985;142-151.
21. Kulmacz, R. J.; Tsai, A. L.; Palmer, G. Heme spin states and peroxide induced radical species in prostaglandin H synthase. J. Biol. Chem. 262:10542-10531; 1987.
22. Chamulitrat W., Mason R. P. Lipid peroxyl radicals intermediates in the peroxidation of polyunsaturated fatty acids by lipooxygenase. J. Biol. Chem. 264:1989;20968-20973.
23. Handin R. I., Karabin R., Boxer G. J. Enhancement of platelet function by superoxide anion. J. Clin. Invest. 59:1977;959-965.
24. Canoso R. T., Rodvien R., Scoon K., Levine P.H. Hydrogen peroxide and platelet function. Blood. 43:1974;645-655.
25. Levine P. H., Weinger R. S., Simon J., Scoon K. L., Krinsky N. I. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J. Clin. Invest. 57:1976;955-962.
26. Clark R. A., Seymour J., Klebanoff J. Neutrophil platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J. Immunol. 124:1980;399-403.
27. Ohyashiki T., Kobayashi M., Matsui K. Oxygen-radical-mediated lipid peroxidation and inhibition of ADP-induced platelet aggregation. Arch. Biochem. Biophys. 288:1991;282-286.
28. 2 pool generated by human neutrophils. J. Biol. Chem. 259:1984;399-405.
29. 2-dependent platelet aggregation. Platelets. 2:1992;87-90.
30. Praticò D., Iuliano L., Pulcinelli F. M., Bonavita M. S., Gazzaniga P. P., Violi F. Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. J. Lab. Clin. Med. 119:1992;364-370.
31. Praticò D., Iuliano L., Alessandri C., Camastra C., Violi F. Polymorphonuclear leukocyte-derived O2 reactive species activate primed platelets in human whole blood. Am. J. Physiol. 264:1993;H1582-1587.
32. Iuliano L., Violi F., Pedersen J. Z., Praticò D., Rotilio G., Balsano F. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch. Biochem. Biophys. 299:1992;220-224.
33. 2 activation. Arch. Biochem. Biophys. 289:1991;47-52.
34. 2. Arterioscler. Thromb. Vasc. Biol. 15:1995;1131-1138.
35. Marcus A. J. Thrombosis and inflammation as multicellular processes: Pathophysiologic significance of transcellular metabolism. Blood. 76:1990;1903-1907.
36. Hornberger W., Patscheke H. Primary stimuli of icosanoid release inhibit arachidonyl-CoA synthetase and lysophospholipid acyl transferase. Eur. J. Biochem. 187:1990;175-181.
37. Miller, C. C.; Hale, P.; Pentland, A. P. Ultraviolet B injury increase prostaglandin synthesis through atyrosine kinase dependent pathway. J. Biol. Chem. 269:3529-3523; 1994.
38. 2+ dependent mechanism. Arch. Biochem. Biophys. 270:1989;478-488.
39. Clark E. A., Brugge J. S. Tyrosine phosphorylation in platelets. Potential role in intracellular signal transduction. Trends. Cardiovasc. Med. 3:1993;218-227.
40. Gold A., Brugge J. S., Shattil S. Role of platelet membrane glycoprotein IIb/IIIa in agonist-induced tyrosine phosphorylation of platelet protein. J. Cell. Biol. 111:1990;3117-3127.
41. 2 and vanadate in vitro. Biochem. Biophys. Res. Comm. 188:1992;773-779.
42. · cells transfected with human EGF receptor. Biochem. J. 274:1991;715-721.
43. 2 iscoupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6147-6151.
44. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
45. Chao T. S., Byron K. L., Lee K. M., Villereal M., Rosner M. R. Activation of MAP kinasesbycalcium-dependent and calcium independent pathways. Stimulation by thapsigargin and epidermal growth factor. J. Biol. Chem. 267:1992;19876-19883.
46. Fialkow L., Chan C. K., Grinstein S., Downey G. P. Regulation of tyrosine phosphorylation in neutrophils by the NADPHoxidase. Role of reactive oxygen intermediates. J. Biol. Chem. 268:1993;17131-17137.
47. Taylor L., Menconi M. J., Polgar P. The participation of hydroperoxides and oxygen radicals in the control of prostaglandin synthesis. J. Biol. Chem. 258:1983;6855-6857.
48. Praticò D., Iuliano L., Ghiselli A., Alessandri C., Violi F. Hydrogen peroxide as trigger of platelet aggregation. Haemostasis. 21:1991;169-174.
49. Halliwell B., Grootveld M., Gutteridg J. M. Methods for the measurement of hydroxyl radicals in biochemical systems: Deoxyribose degradation and aromatic hydroxylation. Methods Biochem. Anal. 33:1988;59-90.
50. Iuliano L., Violi F., Ghiselli A., Alessandri C., Balsano F. Dipyridamole inhibits lipid peroxidation and scavenges oxygen free radicals. Lipids. 24:1989;430-433.
51. Iuliano L., Praticò D., Ghiselli A., Bonavita M. S., Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids. 27:1992;349-353.
52. Iuliano L., Pedersen J. Z., Rotilio G., Ferro D., Violi F. A potent chain breaking antioxidant activity of the cardiovascul drug dipyridamole. Free Rad. Biol. Med. 18:1995;239-247.
53. Violi F., Praticò D., Ghiselli A., Alessandri C., Iuliano L., Cordova C., Balsano F. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. Atherosclerosis. 82:1990;247-252.
54. Violi F., Alessandri C., Praticò D., Guzzo A., Ghiselli A., Balsano F. Inhibition of cyclooxygenase-independent platelet aggregation by sodium-salicylate. Thromb. Res. 54:1989;583-593.
55. Violi F., Praticò D., Iuliano L., Balsano F. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). J. Lipid. Mediators. 4:1991;61-68.
56. Blough N. V., Zafiriou O. C. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorg. Chem. 24:1985;3502-3505.
57. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
58. 2 and arterial prostacyclin by dietary vitamin E. Prostaglandins. 22:1981;651-661.
59. Hamelin S. St.-J., Chan A. C. Modulation of platelet thromboxane and malonaldehyde by dietary vitamin E and linoleate. Lipids. 18:1983;267-269.
60. Pritchard K. A., Greco N. J., Panganamala R. V. Effect of dietary vitamin E on the production of platelet 12-hydroxyeicosatetraenoic acid (12-HETE). Thromb. Haemostas. 55:1986;6-7.
61. 2. Biochim. Biophys. Acta. 876:1986;639-645.
62. 2 and lyso-PAF in male volunteers. Clin. Exp. Pharmacol. Physiol. 17:1990;645-651.
63. Kockmann V., Vericel E., Croset M., Lagarde M. Vitamin E fails to alter the aggregation and the oxygenated metabolism of arachidonic acid in normal human platelets. Prostaglandins. 36:1988;607-620.
64. Steiner M., Anastasi J. Vitamin E. An inhibitor of the platelet release reaction. J. Clin. Invest. 57:1976;732-737.
65. Agradi E., Petroni A., Socini A., Galli C. In vitro effects of antioxidants and vitamin E on archidonic acid metabolism and thromboxane formation in human platelet aggregation. Prostaglandins. 22:1981;255-266.
66. Vatassery G. T., Krezowski A. M., Eckfeld J. H. Vitamin E concentration in human blood plasma and platelets. Am. J. Clin. Nutr. 37:1983;1020-1024.
67. Kitagawa M., Mino M. Effects of elevated d-alpha (RRR)- tocopherol dosage in man. J. Nutr. Sci. Vitaminol. 35:1989;133-142.
68. Chadwick A., Rao G. H. R., Gerrard J. M., White J. G. The influence of viatamin E quinone on platelet structure, function, and biochemistry. Blood. 55:1980;907-914.
69. Cordova C., Musca A., Violi F., Perrone A., Alessandri C. Influence of ascorbic acid on platelet aggregation in vitro and in vivo. Atherosclerosis. 41:1982;15-19.
70. 2+ increase, ATP secretion and aggregation of aspirinated human platelet. Biochem. Byophys. Res. Comm. 139:1986;509-514.
71. FitzGerald G. A. Dipyridamole. N. Engl. J. Med. 316:1987;1247-1257.
72. Davì G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N. Engl. J. Med. 322:1990;1769-1774.
73. Watanabe J., Umeda F., Wakasugi H., Ibayashi H. Effect of vitamin E of platelet aggregation in diabetes mellitus. Thromb. Haemost. 51:1984;313-316.
74. Colette C., Pares-Herbute N., Monnier L. H., Cartry E. Platelet function in type I diabetes: Effects of supplementation with large doses of vitamin E. Am. J. Clin. Nutr. 47:1988;256-261.
75. Yao S., Ober J. C., Gonenne A., Clubb F. G., Krishuaswami A., Ferguson J. J., Anderson H. V., Gorecki M., Buya L. M., Willerson J. T. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ. Res. 73:1993;952-967.
76. Ikieda H., Koga Y., Oda T., Kerwano K., Nakayama H., Neno T., Toshiura H., Michael L., Euxuran M. L. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J. Am. Coll. Cardiol. 24:1994;1749-1756.